Patient Guide: QuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 in HER2-low Metastatic Breast Cancer

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 36 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06551116
Status: 🟢 Enrolling Now
Condition: HER2-positive Metastatic Breast Cancer
Phase: Not Specified

Where You Can Participate

This study is available at 36 locations across the country.

Top locations include:
  • • San Francisco, California
  • • Derby, Connecticut
  • • Fairfield, Connecticut
  • • And 33 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

QuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 in HER2-low Metastatic Breast Cancer - Join Clinical Trial NCTNCT06551116

How to Join This Clinical Trial - NCTNCT06551116

Learn how to participate in this Not Specified trial studying an investigational therapy for HER2-positive Metastatic Breast Cancer. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with HER2-positive Metastatic Breast Cancer. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
HER2-positive Metastatic Breast Cancer
Treatment Being Tested
Investigational treatment
Study Phase
Not Specified - Research study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT06551116 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 36 locations. Find a study site near you:

Clinical Research Site

San Francisco, California 94143 - United States

Status: RECRUITING

Clinical Research Site

Derby, Connecticut 06418 - United States

Status: RECRUITING

Clinical Research Site

Fairfield, Connecticut 06824 - United States

Status: RECRUITING

Clinical Research Site

Glastonbury, Connecticut 06033 - United States

Status: RECRUITING

Clinical Research Site

Greenwich, Connecticut 06830 - United States

Status: RECRUITING

Clinical Research Site

Guilford, Connecticut 06437 - United States

Status: RECRUITING

Clinical Research Site

Hartford, Connecticut 06105 - United States

Status: RECRUITING

Clinical Research Site

New Haven, Connecticut 06473 - United States

Status: RECRUITING

Clinical Research Site

New Haven, Connecticut 06511 - United States

Status: RECRUITING

Clinical Research Site

Stamford, Connecticut 06901 - United States

Status: RECRUITING

And 26 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this Not Specified clinical trial for HER2-positive Metastatic Breast Cancer:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships